LongevityCellular Health

Epithalon (Epitalon)

Telomerase activator for life extension and circadian rhythm

Overview

Epithalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide derived from the pineal gland. It is considered the 'gold standard' in longevity research for its ability to activate telomerase (elongating telomeres) and restore the body's natural melatonin production. Research indicates it can reset the circadian clock and delay cellular aging.

Chemical Information

IUPAC Name
L-Alanyl-L-Glutamyl-L-Aspartyl-Glycine
Sequence
Ala-Glu-Asp-Gly
Molecular Mass
390.4 Da
Formula
C14H22N4O9
Epithalon (Epitalon) Chemical Structure

Mechanism of Action

Functions as a Telomerase Activator and Epigenetic Regulator. 1. Telomere Elongation: It induces the expression of the catalytic subunit of telomerase (TERT) in somatic cells. This allows cells to overcome the 'Hayflick Limit' (the max number of times a cell can divide), effectively reversing cellular age at the DNA level. 2. Chromatin Remodeling: It binds to specific DNA sequences to 'unroll' silent heterochromatin, activating antioxidant defense genes (SOD, Glutathione Peroxidase). 3. Pineal Restoration: It restores the sensitivity of the pineal gland to light cues, normalizing melatonin and cortisol rhythms, which is critical for deep sleep and immune function in the elderly.

Potential Research Fields

Telomere BiologyGerontologyCircadian RhythmsCancer PreventionRetinal Regeneration

Recent Research

As the flagship 'Khavinson Peptide,' Epithalon remains the subject of long-term longevity studies. Research consistently highlights its ability to induce telomerase activity, effectively 'adding time' to the cellular clock. In 2024, interest has renewed in its role in circadian medicine. Studies suggest that by rejuvenating the pineal gland, Epithalon does not just provide melatonin, but restores the body's ability to produce it naturally, correcting the fragmented sleep architecture seen in dementia and advanced aging. It is also being investigated for retinal regeneration in degenerative eye diseases.

Bibliography / Scientific References

Related Peptides

Peptide Information Guide
Administration Type
Injectable (Intramuscular / Subcutaneous)

Injectable administration protocol for research.

Vial Strength
50mg
Reconstitution
Reconstitute with 2.5ml bacteriostatic water
Dosage Options
10 mg (50 units)
Daily x 10 Days
High Dose Protocol: Intramuscular. Repeat 2x/year. (50mg/2.5ml = 20mg/ml)
5 mg (25 units)
Daily x 20 Days
Standard Protocol: Subcutaneous/IM at night. Repeat 2x/year.
Schedule
1x daily
Timing: One specific day.
Duration
See Options
Potential Side Effects
Injection site soreness
lowoccasional
Research Use Only

This information is for research purposes only. Always consult with a healthcare professional before starting any peptide protocol. Individual responses may vary, and proper medical supervision is recommended for all peptide therapies.